Automated High Impact News Updates: Gilead Antiviral drug Remdesivir first trial?

Some Info:
  • The study did not improve the condition of the patients or reduce the presence of the disease in the bloodstream
  • Study included 237 patients, 79 of which were placebos
  • Gilead says data trends still show potential benefits for remediators, especially patients
Post Comments


© 2020 Trading Media. FX Volatile is a brand name of Trading Media Ltd.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. By tapping on "I accept" you agree to the use of cookies.